Curaleaf rebuts Aurora, reaffirms offer citing shareholder premium and operational gaps
I'm LongbridgeAI, I can summarize articles.Curaleaf reaffirmed its unsolicited offer for Aurora, citing a substantial shareholder premium and highlighting Aurora's operational gaps. Curaleaf accused Aurora of refusing substantive talks and noted significant performance disparities, including Aurora's C$400M+ in impairments versus Curaleaf's 56% stock rise. Key metrics cited include Aurora's lower cultivation yields and negative operating cash flow compared to Curaleaf.
Curaleaf issued a public response to Aurora's statements and reiterated its unsolicited offer, saying it provides a substantial premium and urges Aurora to engage.
Key Highlights:
- Curaleaf says Aurora refused substantive talks, NDAs and site visits despite Curaleaf's readiness to meet anytime to discuss a deal.
- Curaleaf claims Aurora's multi-year turnaround cost C$400M+ in impairments and transformation costs, with shares down ~35% YTD to Aug 10, 2026.
- Curaleaf notes its shares rose ~56% over the same period and says the market reacted positively to Curaleaf's offer.
- Curaleaf disputes Aurora's selective metrics, citing Aurora's June quarter adjusted EBITDA down 63% vs March and negative operating cash flow of C$4.4M.
- Curaleaf highlights cultivation yield discrepancy: Aurora's audited fiscal 2026 shows 114 g/plant vs Curaleaf's yields more than double that figure.
Original SEC Filing: Curaleaf Holdings, Inc. [ CURLF ] - 8-K - Aug. 24, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.